Glaucoma News

SAN FRANCISCO — A clinical study of NGoggle, a virtual reality device that aims to detect glaucoma, will begin at Duke University, according to a press release from the National Eye Institute, which is funding the investigation.

A literature search found a strong correlation between intravitreal injection and immediate IOP elevation, while the association with long-term IOP rise and glaucoma is less certain.

SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, co-founders Adrienne L. Graves, PhD, and Andrew G. Iwach, MD, discuss the meeting’s dedication to innovation in the glaucoma space.

WAIKOLOA, Hawaii — Joel S. Schuman, MD, discusses how current technology allows all ophthalmologists to get objective, quantitative information about the optic nerve, IOP and visual fields to allow the highest levels of care, whether at a remote setting or the most sophisticated practice, here at Hawaiian Eye 2019.

SAN ANTONIO – Virtual Field launched its virtual reality platform for visual field testing during a press conference here at the American Academy of Optometry meeting.

In eyes with glaucoma, as well as in healthy eyes, femtosecond laser-assisted cataract surgery leads to an initial IOP rise, followed by significant decrease at 1 month. Reduction is sustained in eyes with glaucoma over 3 years, according to a study.

A majority of patients called in for confirmatory eye exams due to unreadable fundus images taken during their initial exams were found to have glaucoma, according to a study published in Journal of Glaucoma.

Santen Pharmaceutical Co. is eyeing the North American market and planning to launch products for glaucoma and retina disease, Shigeo Taniuchi, president and chief operating officer, said at the 37th annual J.P. Morgan Healthcare Conference.

WAIKOLOA, Hawaii — Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the company’s product development in glaucoma and retina treatments here at Hawaiian Eye 2019.

WAIKOLOA, Hawaii ― At Hawaiian Eye 2019, Shlomo Melamed, MD, discusses the CO2 laser-assisted sclerectomy nonpenetrating procedure that unroofs Schlemm’s canal to lower IOP in patients with glaucoma.